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Ume˚ a, Sweden
The aim of this study was to investigate the effects of
elevated glucose concentrations on complement receptor–
andFcγ receptor–mediatedphagocytosisinnormalhuman
neutrophils. D-Glucose at 15 or 25 mM dose-dependently
inhibited both complement receptor– and Fcγ receptor–
mediated phagocytosis, as compared to that at a normal
physiological glucose concentration. The protein kinase
C (PKC) inhibitors GF109203X and Go6976 both dose-
dependentlyandcompletelyreversedtheinhibitoryeffectof
25 mM D-glucose on phagocytosis. Complement receptor–
mediated phagocytosis was dose-dependently inhibited by
the cell permeable diacylglycerol analogue 1,2-dioctanoyl-
sn-glycerol (DAG), an effect that was abolished by PKC
inhibitors. Furthermore, suboptimal inhibitory concentra-
tions of DAG and glucose showed an additive inhibitory ef-
fect on complement receptor–mediated phagocytosis. The
authors conclude that elevated glucose concentrations can
inhibit complement receptor and Fcγ receptor–mediated
phagocytosis in normal human neutrophils by activating
PKCα and/or PKCβ, an effect possibly mediated by DAG.
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An important complication in diabetes mellitus is an in-
creased sensitivity to infection, leading to many secondary dis-
eases[1].Thismayinpartbeexplainedbyanimpairedfunction
of neutrophil granulocytes [2, 3]. In fact, numerous studies of
neutrophils from patients with diabetes mellitus have reported
defects in many important functional steps, such as adher-
ence, chemotaxis, respiratory burst, phagocytosis, and bacte-
rialkilling[4–7].Althoughdefectiveneutrophilfunctionseems
to be closely related to poorly controlled diabetes and high
glucose levels, the cellular/molecular mechanisms underlying
the impaired neutrophil function in diabetes are still not well
understood.
Effectivephagocytosisofinvadingpathogensbyneutrophils
is of signiﬁcant importance for successful resistance to infec-
tious diseases [8]. Phagocytosis is a complicated process that
can be activated by several different types of prophagocytic
receptors, where two of the best characterized are Fcγ recep-
tors for the Fc portion of immunoglobulin G (IgG) on IgG-
opsonized targets and complement receptor 3 (CR3) that will
recognize C3bi-opsonized targets [8]. Conﬂicting data have
been reported about the in vitro phagocytic capacity of neu-
trophilsfrompatientswithdiabetesmellitus,showingbothnor-
mal [5–7] as well as decreased phagocytosis activity [2, 9–11].
Interestingly, increased glucose concentrations were found to
impair phagocytosis of IgG-opsonized Staphylococcus aureus
by normal human neutrophils [12], whereas phagocytosis of
C3bi-opsonized Staphylococcus aureus was unaffected by ele-
vated glucose concentrations [13]. These ﬁndings suggest that
Fcγ receptor–mediated phagocytosis is more sensitive to ele-
vatedglucoseconcentrationsthanisCR3-mediatedphagocyto-
sis. However the exact mechanisms by which hyperglycemia
125126 D. SAIEPOUR ET AL.
may affect the phagocytic capacity of neutrophils is still
unclear.
The aim of this study was to investigate the effects of el-
evated glucose concentrations on phagocytosis of C3bi- and
IgG-opsonized yeast particles in normal human neutrophils.
MATERIALS AND METHODS
Chemicals
Electrophoretically homogenous, lyophilized bovine serum
albumin (BSA) was from Boehringer Mannheim Scandinavia
AB, Stockholm, Sweden. GF109203X was from Calbiochem,
La Jolla, CA, USA. Go6976 was from LC Laboratories,
Woburn, MA, USA. May-Gr¨ unwalds reagent was from
Apoteksbolaget, Malm¨ o, Sweden. 1,2-Dioctanoyl-sn-glycerol
(DAG), ﬂuorescein isothiocyanate (FITC) mixed polymers,
and phorbol 12-myristate 13-acetate (PMA) were from Sigma
Chemical, St. Louis, MO, USA. Polymorphprep was from
Nycomed Pharma, Oslo, Norway. Rabbit anti-yeast IgG was
a generous gift of Dr. Maria F¨ allman, Ume˚ a University,
Sweden. Crystalline tannic acid was from Ketsen, Stockholm,
Sweden. PMA, GF109203x and Go6976 were dissolved in
dimethylsulfoxide (DMSO) and stored at −20◦C. The highest
ﬁnal DMSO concentration in the experiments was 0.1% (v/v)
and equal concentrations of DMSO were included in the
controls. Double-distilled water was used throughout and all
reagents used were of analytical grade.
Media
Krebs-Ringer Hepes (KRH) medium containing (in mM):
NaCl 136, KCl 4.7, KH2PO4 1.2, MgSO4 1.2, NaHCO3 5,
Hepes20, D-glucose5,CaCl2 1.1,supplementedwith1mg/mL
BSA,pH7.40,wasusedinallexperiments.Phosphate-buffered
saline (PBS) containing (in mM): Na2HPO4 8.1, KCl 2.7,
KH2PO4 1.5, and NaCl 137, pH 7.40, was used to wash the
cells during isolation and staining.
Isolation of Neutrophil Granulocytes
Heparinized venous blood was obtained from healthy adult
volunteers attending the Blood Bank at the Ume˚ a University
Hospital. The study was performed in accordance with the eth-
ical standards of the 1964 Declaration of Helsinki and all blood
donors gave their informed verbal consent. Neutrophil granu-
locytes were isolated essentially using the method of B¨ oyum
[14]. In short, blood was layered on top of Polymorphprep and
spun in a centrifuge at 450 to 500 × g and room temperature
for30minutes.Theneutrophillayerwasthencollectedandfol-
lowing a brief hypotonic lysis of remaining erythrocytes, using
distilled water, the neutrophils were washed 3 times in PBS at
200×g for5minutesandﬁnallysuspendedat1×106 cells/mL
inKRH.Thecellsuspensionwaskeptatroomtemperatureuntil
used, which was within 1 hour.
Preparation and Opsonization of Yeast Particles
Opsonizedyeastparticleswerepreparedessentiallyasprevi-
ouslydescribed[15].Forcomplementopsonization,heatkilled
FITC-labeled or unlabeled yeast particles were incubated with
20% normal human serum in KRH at 37◦C for 30 minutes. For
IgG opsonization, heat killed yeast particles were incubated
with puriﬁed rabbit anti-yeast IgG (24 µg/mL) in the presence
of 20% heat-inactivated (56◦C, 30 minutes) human serum in
KRH at 37◦C for 30 minutes. All particles were then washed
twice,resuspendedat1×108/mLinKRH,andkeptoniceuntil
used, which was within 2 hours.
Measurement of Phagocytosis
Formeasurementsofphagocytosis,neutrophils(1×106/mL)
were ﬁrst incubated in suspension with 5, 15, or 25 mM
D-glucose at 37◦C for 30 minutes. DAG, protein kinase C
(PKC) inhibitors, and PMA, when used, were added during
the last 5 minutes prior to the addition of yeast particles. C3b-
opsonized yeast (C3bY) or IgG-opsonized yeast (IgGY) par-
ticles were then added to the neutrophils, which were further
incubated at 37◦C for 15 minutes. The tubes were then put on
ice for 15 minutes to stop the phagocytosis process. Phagocy-
tosis was evaluated either by light microscopy according to the
method by Giaimis and colleagues [16] or by ﬂow cytometry
using FITC-labeled yeast particles [15]. For light microscopic
evaluation of phagocytosis, neutrophils from each sample were
attached to glass slides. To visually separate ingested yeast par-
ticles from extracellularly bound, noningested particles [16],
slides were then treated with 1% (w/v) tannic acid in PBS for
1 minute at room temperature. Next, slides were stained with
May-Gr¨ unwalds reagent for 5 minutes and ﬁnally washed with
H2O for another 5 minutes. Tannic acid will not get access
to ingested yeast particles, but will only etch the extracellu-
larly bound yeast. Therefore, by using this method, ingested
yeast particles will have a light pink color whereas extracel-
lularly bound yeast will have a dark purple color. The slides
were allowed to dry at room temperature before microscopic
evaluation. The number of ingested and extracellularly bound
particles was counted by light microscopy. One hundred neu-
trophils were analyzed in each of 3 separate preparations from
eachsample/incubationcondition.Phagocytosiswasexpressed
as a phagocytosis index showing number of ingested yeast par-
ticles per 100 neutrophils.
For ﬂow cytometric evaluation of phagocytosis, opsonized
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assay, as described above. Following phagocytosis, samples
on ice were mixed with trypan blue (1% ﬁnal concentration)
to quench the ﬂuorescence of yeast particles that were not
fully ingested by the neutrophils. Phagocytosis was quantiﬁed
by using FACscan ﬂow cytometry (BD Biosciences, Mountain
View, CA, USA) and analyzed using CellQuest software (BD
Biosciences). Sufﬁcient quenching of noningested yeast was
conﬁrmed by comparing the ﬂuorescence signal from FITC
yeast, with or without trypan blue. The results obtained by the
2 different methods described above gave virtually identical
results.
Statistics
Statistical analyses were performed by using the two-tailed
Student’s t test for paired or unpaired samples (see legends
to the ﬁgures and table). All results are expressed as mean±
SEM.
RESULTS
Elevated Glucose Concentrations Inhibit
Ingestion of C3b- and IgG-Opsonized
Yeast Particles
To study the effects of elevated glucose concentrations on
complement receptor-mediated phagocytosis, C3bY were pre-
sented to neutrophils in suspension. Following a 30-minute
preincubation with 15 mM or 25 mM glucose, phagocytosis
of C3bY was dose-dependently reduced to 73.2%±4.7% and
42.5% ± 2.7% of that seen at 5 mM glucose (P <. 01 and
P <. 001 respectively), (Figure 1A). We next studied the
effects of elevated glucose concentrations on Fcγ receptor–
mediated phagocytosis, by using IgGY. Also here, phagocyto-
sis was dose-dependently reduced by 15 and 25 mM glucose
to 66.8%±6.8% and 52.6%±8.1% of that at 5 mM glucose
(P <. 01 and P <. 001 respectively) (Figure 1A). When the
roleoftheC3bY/neutrophilratiowasstudied,wefoundaslight
reduction of the inhibitory effect of 15 or 25 mM glucose when
the C3bY/neutrophil ratio was increased (Figure 2A, B). Thus,
elevated glucose concentrations can dose-dependently inhibit
phagocytosis in normal human neutrophils.
The inhibitory effect of glucose on neutrophil phagocyto-
sis could be the result of either a reduced binding of C3bY
or IgGY to neutrophil complement or Fcγ receptors, or due
to a reduced ingestion of yeast particles bound to the cell sur-
face, or both. The total number of neutrophil-associated yeast
particles (C3bY), both ingested and bound to the outside of
the neutrophils, was affected by glucose to a rather low ex-
tent (232 ± 8 C3bY/100 neutrophils at 25 mM glucose versus
FIGURE 1
Elevated D-glucose concentrations inhibit complement
receptor– and Fcγ receptor–mediated phagocytosis in
nonadherent normal human neutrophils. Neutrophils were
incubated in suspension with 5, 15, or 25 mM D-glucose in
Krebs-Ringer Hepes medium for 30 minutes at 37◦C before
addition of C3bi- (C3bY) or IgG-opsonized (IgGY) yeast
particles (yeast/neutrophil ratio 100:1) for an additional
15 minutes at 37◦C. (A) Phagocytosis was quantiﬁed by light
microscopy, as described in Materials and Methods, and
expressed as percent of that at 5 mM D-glucose. ∗∗P <. 01
and ∗∗∗P <. 001, as compared with that at 5 mM glucose,
using Student’s t test for paired comparisons. Values are
mean±SEM for 6 separate experiments. (B) Phagocytosis of
C3bY quantiﬁed by ﬂow cytometry showed virtually similar
results. ∗P <. 05, as compared with that at 5 mM glucose,
using Student’s t test for paired comparisons. Values are
mean±SEM for 6 separate experiments.
265 ± 10 C3bY/100 neutrophils at 5 mM glucose; P <. 05)
(Table 1). When the total number of cell-associated IgGY was
analyzed in the same way, there was a nonsigniﬁcant decrease
in the total number of cell-associated IgGY in the presence
of 25 mM glucose (144±37 IgGY/100 neutrophils), as com-
paredtothatat5mMglucose(194±12IgGY/100neutrophils)
(P >. 05; Table 1).
The small effects of elevated glucose concentrations on the
total number of neutrophil-associated yeast particles could be
explained by the glucose-induced reduction in phagocytosed
particles and not by an impairment of the binding of yeast par-
ticlestocomplementorFcγ receptors.Itisthereforemostlikely
thattheinhibitoryeffectsofelevatedglucoseconcentrationsare128 D. SAIEPOUR ET AL.
FIGURE 2
The yeast/neutrophil ratio does not affect the inhibitory effects
of 15 or 25 mM glucose on complement receptor–mediated
phagocytosis in nonadherent normal human neutrophils.
Neutrophils, preincubated with 5, 15, or 25 mM glucose, were
allowed to phagocytose C3bY, as described in the legend to
Figure 1, at the indicated yeast/neutrophil ratios. Phagocytosis
was quantiﬁed by light microscopy and is expressed as
(A) number of ingested yeast particles/100 neutrophils or
(B) the relative inhibitory effect of 15 or 25 mM glucose, as
compared to that at 5 mM glucose. Quantiﬁcation of
phagocytosis using ﬂow cytometry showed virtually similar
results. ∗∗P <. 01 and ∗∗∗P <. 001, as compared with that at
5 mM glucose, using Student’s t test for paired comparisons.
Values are mean ± SEM for 4 to 6 separate experiments.
TABLE 1
Total number of neutrophil-associated yeast particles
Glucose (mM)
Target 5 15 25
C3bY 265 ± 10 248 ± 5 232 ± 8∗
IgGY 194 ± 12 ND 144 ± 37
Note. Phagocytosis experiments with nonadherent neutrophils in
suspension were performed as described in Materials and Methods.
For each glucose concentration, all yeast particles associated with
the neutrophils, both ingested and bound to the cell surface, were
counted. In each experiment, 300 neutrophils were counted in each
group. Values are mean±SEM of the numbers of yeast particles/100
neutrophils in 3 to 6 separate experiments. ∗P <. 05 as compared
with 5 mM glucose in the same group, using Student’s t test for paired
comparisons. ND = not determined.
acting speciﬁcally on the ingestion process following comple-
ment or Fcγ receptor engagement by particulate stimuli. We
therefore decided to further speciﬁcally investigate the under-
lying mechanisms behind the decreased ingestion of C3bY and
IgGY.
Decreased Phagocytosis of C3bY at Increased
Glucose Concentration Is Not An
Osmotic Effect
To determine whether the inhibitory effects of high glucose
concentrations on phagocytosis in neutrophils was an osmotic
effect,weexaminedtheeffectsofthetransportedbutnonmetab-
olizable glucose analogue 3-oxy-methyl-D-glucose (3-OMG),
andofthenontransportedstereoisomerL-glucose,onthephago-
cytosis of C3bY. The results showed no signiﬁcant changes in
phagocytosis by these 2 sugars at 15 or 25 mM, indicating that
the effects of high glucose concentrations were not secondary
to an osmotic effect (Figure 3).
Dose-Dependent Inhibitory Effects of PMA on
Neutrophil Phagocytosis of C3bY and IgGY
In other cell types, exposure to elevated glucose concen-
trations may induce cellular dysfunction by the activation of
PKC [17, 18]. As the exact role of PKC activation in neutrophil
phagocytosisisnotfullyunderstood,wenexttestedtheeffectof
the PKC activator PMA on neutrophil phagocytosis of C3bY
and IgGY in our system. The rate of phagocytosis decreased
dose-dependently in a similar way for both C3bY and IgGY at
1n Mt o1µM PMA (Figure 4). Thus, PKC activation by PMA
can decrease the rate of complement or Fcγ receptor–mediated
phagocytosis of yeast particles in normal human neutrophils.HYPERGLYCEMIA EFFECTS ON NEUTROPHIL PHAGOCYTOSIS 129
FIGURE 3
The inhibitory effect of 15 or 25 mM glucose on neutrophil
phagocytosis is not an osmotic effect. Neutrophils were
incubated in suspension with increasing concentrations of
D-glucose (open bars), 3-OMG (hatched bars), or L-glucose
(closed bars) for 30 minutes at 37◦C before addition of C3bY
(yeast/neutrophil ratio 100:1). In the samples containing
3-OMG and L-glucose, 5 mM D-glucose was mixed with
10 mM or 20 mM 3-OMG and L-glucose as a source of
energy. Phagocytosis was scored as described in the legend to
Figure 1, and expressed in percent of that at 5 mM D-glucose
(56.3±3.3 C3bY/100 neutrophils). ∗∗P <. 01 and
∗∗∗P <. 001, as compared with that at 5 mM glucose, using
Student’s t test for paired comparisons. Values are
mean±SEM for 6 separate experiments.
The PKC Inhibitors GF109203X or Go6976
Can Reverse the Inhibitory Effects of Elevated
Glucose Concentrations on Phagocytosis
of C3bY and IgGY
Iftheglucose-mediatedinhibitoryeffectsonphagocytosisof
C3bYandIgGYinneutrophilsaremediatedbyPKCactivation,
a PKC inhibitor should reverse that effect. To investigate the
possible inhibitory effects of glucose-mediated PKC activation
in phagocytosis of opsonized yeast particles in our system, we
tested the effect of 2 speciﬁc PKC inhibitors, GF109203X, an
inhibitor of the α, β, δ, and ε isoforms of PKC, and Go6976, an
inhibitoroftheα andβ isoformsofPKC.AsseeninFigure5A,
addition of GF109203X at 10 nM to 1 µM dose-dependently
reversed the inhibitory effect of 25 mM glucose, with an al-
FIGURE 4
The PKC agonist PMA can dose-dependently inhibit
complement receptor– and Fcγ receptor–mediated
phagocytosis in normal human neutrophils. Neutrophils were
preincubated with 0 to 1000 nM PMA for 5 minutes in
suspension, followed by phagocytosis of C3bY or IgGY
(yeast/neutrophil ratio 100:1), as described in the legend to
Figure 1. Phagocytosis is expressed as percent of that at 5 mM
D-glucose. Quantiﬁcation of phagocytosis using ﬂow
cytometry showed virtually similar results. ∗∗P <. 01 and
∗∗∗P <. 001, as compared with that at 5 mM glucose, using
Student’s t test for paired comparisons. Values are
mean±SEM for 6 separate experiments.
most normalized phagocytosis at 1 µM GF109203X. This is
in good agreement with our previous ﬁndings where 1 µMo f
GF109203X could completely abolish PMA-induced superox-
ide secretion from human neutrophils [19]. In the same way,
Go6976 at 0.1 to 10 µM was also found to dose-dependently
reverse the inhibitory effects of 25 mM glucose on neutrophil
phagocytosis of both C3bY (Figure 5B) and IgGY (data not
shown). Also here, we conﬁrmed that 10 µM Go6976 could
completely inhibit PMA-induced superoxide secretion in neu-
trophils(datanotshown).Thus,inhibitionofthePKCisoforms
α and β is sufﬁcient to prevent the decreased rate of phagocy-
tosis seen at elevated glucose concentrations.
Diacylglycerol Can Inhibit Phagocytosis
of C3bY
IthasbeensuggestedthatactivationofPKCcanbemediated
by de novo synthesis of DAG from glucose [20]. As the PKC
isoforms α and β can be activated by DAG, we next studied the130 D. SAIEPOUR ET AL.
FIGURE 5
The PKC inhibitors GF109203X (A) or Go6976 (B) can
abolish the inhibitory effects of elevated glucose
concentrations on neutrophil phagocytosis. Neutrophils were
incubated with 5 or 25 mM D-glucose for 30 minutes at 37◦C,
with or without PKC inhibitors added during the last
5 minutes. C3bY, at a yeast/neutrophil ratio of 100:1, were
then added and phagocytosis was allowed to proceed as
described in the legend to Figure 1. Phagocytosis is expressed
in percent of ingested yeast particles/100 neutrophils in
comparison to that at 5 mM D-glucose. Quantiﬁcation of
phagocytosis using ﬂow cytometry showed virtually similar
results. ∗∗P <. 01 and ∗∗∗P <. 001, as compared with that at
5 mM glucose, using Student’s t test for paired comparisons.
Values are mean±SEM for 6 separate experiments.
capacity of the cell permeable DAG analogue 1,2-dioctanoyl-
sn-glycerol to inhibit phagocytosis of C3bY. Figure 6A shows
that DAG dose-dependently inhibited phagocytosis of C3bY,
an effect that could be reversed by the PKC inhibitor Go6976.
As elevated glucose concentrations and DAG inhibited phago-
cytosis in a similar manner, we tested for an additive effect
by a combination of suboptimal inhibitory concentrations of
the 2 substances. Indeed, 10 mM glucose and 0.1 µM DAG
could both inhibit phagocytosis of C3bY by 31.0%±5.6%
and 31.7% ± 11.6%, respectively, as compaired with that at
5 mM glucose only (Figure 6B). The combination of 10 mM
glucose and 0.1 µM DAG further decresed phagocytosis to
57.8% ± 4.4% of that seen at 5 mM glucose only, which was
signiﬁcantly lower than that at 10 mM glucose (P <. 001) or
that at 0.1 µM DAG, respectively (P <. 05; Figure 6B). Thus,
it is possible that the inhibitory effects of elevated glucose con-
centrations on neutrophil phagocytosis is mediated by DAG-
induced activation of PKCα and PKCβ.
DISCUSSION
The present study demonstrates that an increase of the
glucose concentration from 5 mM to 15 or 25 mM can
dose-dependently inhibit both complement receptor– and Fcγ
receptor–mediated phagocytosis in normal human neutrophils.
Our results indicate that the glucose-mediated inhibition of
phagocytosis is not an osmotic effect of glucose or an im-
pairedabilityoftheneutrophilstobindyeastparticlestothecell
surface, but rather a more pronounced effect on the ingestion
process.
It is well known that hyperglycemia may lead to PKC acti-
vation, which may underly insulin resistance and diabetic com-
plications in different tissues [17, 21]. Several PKC isotypes
have been described so far, which fall into different categories
basedonprimarystructureandbiochemicalproperties[22,23].
The PKC isoforms β1and β2, which require phosphatidylserine
(PS) and are activated by Ca2+ and DAG, are the most abun-
dant isoforms found in neutrophils [24, 25]. Also other PKC
isoforms, such as PKCζ and PKCδ, have been found in human
neutrophils [22, 24]. However, the exact role of different PKC
isoforms in neutrophil function is not known in detail.
Elevation of extracellular glucose can result in an increased
PKC activity in the membranous fraction, with a parallel de-
crease in the cytosolic PKC fraction without alteration of the
total PKC activity in endothelial cells [17]. Furthermore, ele-
vation of the blood glucose to more than 11 mM was found to
increase the levels of membrane-bound and cytosolic PKCβ2
in platelets, both from patients with type 2 diabetes mellitus
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FIGURE 6
(A) The cell permeable DAG analogue 1,2
dioctanoyl-sn-glycerol can dose-dependently inhibit
complement receptor mediated–phagocytosis in normal
human neutrophils. Neutrophils were incubated for 5 minutes
at 37◦Cw i t h5m MD-glucose, 0 to 100 µM DAG and 10 µM
Go6976 as indicated, prior to the addition of C3bY. The
neutrophils were allowed to phagocytose C3bY as described
in the legend to Figure 1. Phagocytosis is expressed in percent
of that at 5 mM glucose only. (B) Additive phagocytosis
inhibitory effects of suboptimal inhibitory concentrations of
glucose and DAG. Neutrophils were incubated for 30 min at
37◦Cw i t h5o r1 0m MD-glucose and with 0.1 µM DAG
added during the last 5 minutes prior to the addition of C3bY,
as indicated. Phagocytosis was quantiﬁed by ﬂow cytometry.
Quantiﬁcation of phagocytosis using light microscopy showed
virtually similar results. ∗P <. 05 and ∗∗P <. 01, as
compared with that in medium with 5 mM glucose and no
additives, using Student’s t test for paired comparisons.
aP <. 05, as compared with that in samples with 5 mM
glucose and 0.1 µM DAG; bP <. 001, as compared with that
in samples with 10 mM glucose only, using Student’s t test for
paired comparisons. Values are mean±SEM for 5 separate
experiments.
glucose concentrations can inhibit insulin-induced chemokine-
sis in normal human neutrophils, an effect that was reversed
by the PKC inhibitor GF109203X, suggesting that PKC activa-
tion was mediating the inhibitory effect of glucose on insulin-
induced chemokinesis [19]. Based on these previous observa-
tions, we tested the hypothesis that the inhibitory effect of el-
evated glucose concentrations on neutrophil phagocytosis in
our system was also mediated by glucose-induced PKC acti-
vation. This hypothesis was supported by several observations.
ThePKCactivatorPMAdose-dependentlyinhibitedneutrophil
phagocytosis of both C3bY and IgGY and the speciﬁc PKC in-
hibitors GF109203X (inhibits α, β, δ, and ε isoforms of PKC)
and Go6976 (inhibits the α and β isoforms of PKC) each abol-
ished the inhibitory effects of elevated glucose concentrations
on phagocytosis of C3bY and IgGY. Thus, glucose-induced
PKC activation may also be part of the pathological changes
seen in neutrophils in diabetes mellitus.
Previous observations suggested that activation of PKC in
diabetes could be mediated by de novo synthesis of DAG from
glucose. Such de novo synthesis of DAG has been observed
both in endothelial cells [17] and in neutrophils activated by
β-glucan particles [20]. Therefore, it is interesting to note that
a cell-permeable DAG analogue also dose-dependently inhib-
ited phagocytosis of C3bY by normal neutrophils, an effect
that, like in the case of D-glucose, was completely reversed by
the PKC inhibitor Go6976, suggesting that the effect of DAG
also was mediated by PKCα and/or PKCβ. The additive effect
of suboptimal inhibitory concentrations of glucose and DAG
on phagocytosis further indicates a link between elevated glu-
cose concentrations, DAG-mediated activation of PKC, and an
inhibitory effect on neutrophil phagocytosis.
Interestingly, a few studies in neutrophils, macrophages and
monocytes have shown that activation of PKC is associated
with, and sometimes necessary for some isolated steps in the
phagocytosis process [15, 26]. On the other hand, other stud-
ies showed that glucose-induced activation of PKC could in-
hibit the generation of cytokines such as interleukin-1 (IL-1) in
macrophages [27]. This demonstrates that other cellular func-
tions in phagocytes can also be inhibited by glucose-induced
PKC activation. Moreover, a recent study showed that the PKC
inhibitor GF109203X increased the rate of phagocytosis in
bovine neutrophils [28]. Most studies on the role of PKC ac-
tivation in the phagocytosis process looked at signaling events
very early in the phagocytosis process. In our study design, we
evaluated phagocytosis after a 30-minute preincubation with
various glucose concentrations, followed by a subsequent 15-
minute incubation of neutrophils with opsonized yeast, which
mayinpartexplainthediscrepancywithrespecttoPKCdepen-
dence. Thus, the exact role of PKC activation in phagocytosis
is still to be completely understood.132 D. SAIEPOUR ET AL.
We conclude that the inhibitory effect of elevated glucose
concentrations on phagocytosis of C3bY and IgGY in normal
human neutrophils involve activation of PKCα and/or PKCβ,
possibly through generation of DAG from glucose. The spe-
ciﬁc intracellular signaling mechanisms in the neutrophils that
are affected by such glucose-mediated PKC activation are still
unclear and need further investigation.
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